Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl Bromide | HCID 6332 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 22914458 | HCID 22914458 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 22914417 | HCID 22914417 | 21.2% |
Reaction Steps
3.75 ml (21.8 mmol) of N-ethyldiisopropylamine and 0.94 ml (12.6 mmol) of 1-bromoethane were added to a solution of 1.0 g (3.16 mmol) of 7-(5-aminomethyl-1,2,4-oxadiazol-3-yl)-5-methyl-5,6-dihydro-4H-imidazo[1,5-a]thieno[3,2-f][1,4]diazepin-4-one in 30 ml of dimethylformamide and the mixture was stirred at 70° for 1 hour. The reaction solution was subsequently evaporated, whereupon the residue was partitioned between methylene chloride and 2N sodium carbonate solution. The aqueous phase was washed three times with methylene chloride. The organic phases were dried with magnesium sulfate, filtered and evaporated. The residue obtained was chromatographed (silica gel, methylene chloride/methanol/aqueous ammonia 110:10:1). There were obtained 250 mg (21%) of 7-(5-diethylaminomethyl-1,2,4-oxadiazol-3-yl)-5-methyl-5,6-dihydro-4H-imidazo[1,5-a]thieno[3,2-f][1,4]diazepin-4-one as a colourless foam, Rf=0.56 (silica gel, methylene chloride/methanol/aqueous ammonia 110:10:1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05665718 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-9cdf73a18cbb443ea5b00e79dc7ce72c |
|---|
| Source note | uspto-grants-1997_09 |
|---|